Access Official Technical PDF

Share Summary:LinkedInEmail

DOE technology transfer connects federally funded research and specialized laboratory capabilities with the companies and other organizations that can develop, commercialize, and deploy useful technologies. For industrial automation engineers, system integrators, and operations leaders, this model offers ways to work with national laboratories on technical challenges that may benefit from expertise, equipment, or intellectual property beyond a company’s internal R&D resources.

The Department of Energy’s FY 2015 report describes a broad portfolio of partnerships and commercialization activities. Its central message is that moving technology into use is not a single handoff. It is a process involving researchers, businesses, investors, and other partners, supported by agreements and access to laboratory capabilities.

DOE technology transfer: scale and purpose

In FY 2015, DOE and its laboratories and facilities reported 17,086 technology transfer-related transactions. These included 734 Cooperative Research and Development Agreements (CRADAs), 2,395 Strategic Partnership Projects (SPPs) with non-federal entities, 74 Agreements for Commercializing Technology (ACT), 6,310 active intellectual property licenses, and 7,571 user projects.

The same year, laboratories and facilities reported 1,645 invention disclosures, filed 949 patent applications, received 755 patents, and reported 577 commercialized technologies. These figures describe different stages of innovation: research can generate an invention, which may be protected and licensed, while partnerships and user projects can provide other routes for technical collaboration. The numbers are activity indicators, not targets to maximize. DOE’s stated priority is broad deployment and public benefit, rather than royalty income alone.

Partnership mechanisms for industrial R&D

CRADAs and Strategic Partnership Projects

A CRADA enables a laboratory and one or more partners to collaborate on research and development. In FY 2015, non-federal sponsors contributed $64.8 million through CRADAs. SPPs provide another mechanism for work involving non-federal sponsors; their reported non-federal “funds-in” totaled $249.0 million that year. The report records 2,395 active SPP agreements involving non-federal entities.

For companies, these mechanisms create structured ways to engage laboratory expertise while defining the scope and terms of the work. Whether a project is suited to a CRADA, an SPP, or a different arrangement depends on the purpose of the collaboration and the applicable agreement requirements.

Licensing and commercialization agreements

Licensing can provide a route for businesses to use intellectual property developed through DOE-supported research. The laboratories reported $33.1 million in licensing income and more than $21.2 million in earned royalties in FY 2015. Those financial results are part of the activity, but the report emphasizes that commercialization and deployment—not maximizing income—are the primary objectives.

The ACT pilot was introduced as an additional agreement mechanism intended to offer flexibility and address barriers to non-federal access to laboratory capabilities. DOE extended the pilot through October 2017 to gather further information and evaluate its outcomes. The report recorded 74 ACT agreements in FY 2015, with $30.3 million in non-federal sponsor funds-in.

Access to facilities and technical capabilities

Not every industrial engagement requires a research partnership or license. User projects give external researchers and organizations access to DOE facilities and capabilities. The 7,571 user projects reported in FY 2015 made this the largest category among the activities highlighted in the report. Such access can support work that depends on specialized scientific or technical resources, while connecting external teams with laboratory expertise.

DOE also described shared research facilities and scientific programs with industrial engagement, including user facilities, Energy Innovation Hubs, Bioenergy Research Centers, and Energy Frontier Research Centers. These programs illustrate how collaboration can span multiple stages of research, development, demonstration, and deployment. For automation and manufacturing organizations, the relevant opportunity is to identify whether a laboratory capability or research program aligns with a defined technical need.

What the FY 2015 trends indicate

From FY 2010 through FY 2015, CRADA and non-federal SPP activity remained relatively stable, while licensing activity increased slightly overall. Active licenses rose from 6,224 in FY 2010 to 6,310 in FY 2015. User project counts fluctuated: they peaked at 11,967 in FY 2011, declined through FY 2014, and rose to 7,571 in FY 2015.

The report also noted 1,476 unique small businesses collaborating with laboratories in FY 2015, compared with 929 in FY 2014. These figures show that laboratory partnerships serve organizations of different sizes, although the underlying metrics do not indicate that every engagement leads to a commercial product or deployment.

Practical considerations for potential partners

Industrial organizations considering a laboratory collaboration can begin by clarifying the technical objective and the kind of support needed. Useful questions include:

  • Does the project require joint R&D, access to a facility, or rights to existing intellectual property?
  • What capabilities, equipment, or expertise are needed to address the technical problem?
  • Which agreement mechanism is appropriate for the proposed work?
  • Is there a credible plan for further development and potential deployment?

DOE policy calls for visibility and fair access to laboratory capabilities, streamlined and predictable processes, and partners with viable plans for advancing technologies. Laboratory technology transfer offices help organizations understand opportunities and the processes for working with a specific facility.

Conclusion: make the pathway part of the project plan

DOE technology transfer provides several routes for connecting laboratory research with industrial needs: collaborative R&D, sponsored projects, intellectual property licensing, commercialization agreements, and user access to facilities. The FY 2015 activity data show the breadth of this system, while also underscoring that transaction counts are only indicators of engagement. For technical decision-makers, the practical step is to define the problem, identify the laboratory capability or technology that fits, and select an agreement pathway that supports development toward real-world use.

Access Official Technical PDF

About The Author